Overview
Gaochao Dong practices in Nanjing, China. Dong is rated as a Distinguished expert by MediFind in the treatment of Lung Adenocarcinoma. Their top areas of expertise are Lung Adenocarcinoma, Lung Cancer, Esophageal Cancer, and Non-Small Cell Lung Cancer (NSCLC).
Their clinical research consists of co-authoring 84 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 36 articles in the study of Lung Adenocarcinoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Lung AdenocarcinomaDong isDistinguished. Learn about Lung Adenocarcinoma.
- Advanced
- Lung CancerDong isAdvanced. Learn about Lung Cancer.
- Experienced
- Esophageal CancerDong isExperienced. Learn about Esophageal Cancer.
- Lung MetastasesDong isExperienced. Learn about Lung Metastases.
- Non-Small Cell Lung Cancer (NSCLC)